Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tumeurs solides
- | Specialty :
- Thérapies Ciblées
Extract
A phase I, ascending, multi-dose study of BMS-663513, an agonistic anti-CD137 monoclonal antibody, administered every three weeks to patients with metastatic or locally advanced solid tumors.
Scientific Abstract
en cours d'intégration;